Advertisement
Screener

Unity Biotechnology, Inc. Form PRE 14A: Preliminary proxy statement

Unity Biotechnology, Inc. Form PRE 14A: Preliminary proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-08-01: Form PRE 14A; Period of report 2025-09-18; Description PRE 14A; Document ny20051823x1_pre14a.htm.
  • 2022-08-30: Form PRE 14A; Period of report 2022-10-18; Description PRE 14A; Document ny20005123x1_pre14a.htm.
  • 2022-04-12: Form PRE 14A; Period of report 2022-06-24; Description PRE 14A; Document ubx-pre14a_20220624.htm.
FiledFormPeriod of reportDescriptionDocument
2025-08-01PRE 14A2025-09-18PRE 14Any20051823x1_pre14a.htm
2022-08-30PRE 14A2022-10-18PRE 14Any20005123x1_pre14a.htm
2022-04-12PRE 14A2022-06-24PRE 14Aubx-pre14a_20220624.htm